e-learning
resources
Munich 2006
Monday 04.09.2006
Bronchial asthma – issues in inflammation, prevention and management
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Features of production nitric oxide at patients with a bronchial asthma
O. V. Kozina, V. A. Egorov, E. V. Komjakova, N. N. Chusova (Petropavlovsk-Kamchatski, Russian Federation)
Source:
Annual Congress 2006 - Bronchial asthma – issues in inflammation, prevention and management
Session:
Bronchial asthma – issues in inflammation, prevention and management
Session type:
Thematic Poster Session
Number:
2589
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
O. V. Kozina, V. A. Egorov, E. V. Komjakova, N. N. Chusova (Petropavlovsk-Kamchatski, Russian Federation). Features of production nitric oxide at patients with a bronchial asthma. Eur Respir J 2006; 28: Suppl. 50, 2589
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Changes in nitric oxide production in patients with bronchial asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 588s
Year: 2007
Increased nitric oxide production by neutrophils in bronchial asthma
Source: Eur Respir J 2001; 17: 868-871
Year: 2001
Serum nitric oxide metabolists in bronchial asthma patients
Source: Annual Congress 2008 - Allergy and immunology of asthma and beyond
Year: 2008
Changes in nitric oxide production in patients with COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 190s
Year: 2006
Bronchial and alveolar nitric oxide levels in healthy volunteers and patients with severe asthma
Source: International Congress 2016 – Airway biomarkers
Year: 2016
The nitric oxide (NO) metabolites in monitoring and therapy of bronchial asthma
Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers
Year: 2011
Comparisons for concentration in exhaled nitric oxide between patients with bronchial asthma and COPD
Source: Annual Congress 2007 - Pathophysiology and assessment of COPD
Year: 2007
Airway and systemic nitric oxide pathway in COPD
Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification
Year: 2019
Relationship between exhaled nitric oxide and bronchial hyperreactivity in adult with asthma
Source: Annual Congress 2009 - Airway hyperresponsiveness: mechanism and assessment
Year: 2009
Relation of asthma control and exhaled nitric oxide in patients with bronchial hyperresponsiveness to methacholine
Source: Annual Congress 2013 –New issues in lung function testing
Year: 2013
Increased exhaled nitric oxide in nonatopic asthma
Source: Annual Congress 2003 - Developments and applications with exhaled breath condensate and exhaled air
Year: 2003
Nasal nitric oxide
Source: Eur Respir Monogr 2010; 49: 71-81
Year: 2010
Exhaled nitric oxide in asthma
Source: Eur Respir Monogr 2010; 49: 32-44
Year: 2010
Changes of exhaled nitric oxide during steroid treatment of childhood asthma
Source: Eur Respir J 2002; 19: 1015-1019
Year: 2002
Salbutamol temporarily increases the bronchial production of nitric oxide
Source: Eur Respir J 2007; 30: Suppl. 51, 63s
Year: 2007
Levels of asthma control and exhaled nitric oxide
Source: Annual Congress 2009 - Airway inflammation and asthma control
Year: 2009
Screening with exhaled nitric oxide (ENO) may identify cases with on-going bronchial inflammation but not asthma symptoms
Source: Eur Respir J 2001; 18: Suppl. 33, 38s
Year: 2001
Axial distribution of nitric oxide airway production in unstable asthma patients
Source: Annual Congress 2010 - Lung morbidity on exposure to various agents
Year: 2010
The levels of exhaled nitric oxide in controlled asthmatic patients with and without rhinitis
Source: International Congress 2016 – Airway biomarkers
Year: 2016
Bronchial and alveolar exhaled nitric oxide as a marker of systemic involvement in patients with Crohn‘s disease
Source: Annual Congress 2011 - Role of the biomarkers in airway diseases
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept